Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.

This study is aimed at exploring the possible mechanism of action of the Suanzaoren decoction (SZRD) in the treatment of Parkinson's disease with sleep disorder (PDSD) based on network pharmacology and molecular docking. Traditional Chinese Medicine Systems Pharmacology (TCMSP) was used to screen th...

Full description

Bibliographic Details
Published in:BioMed Research International pp. 1 - 13
Main Authors: Liu, Yan-yun, Yu, Li-hua, Zhang, Juan, Xie, Dao-jun, Zhang, Xin-xiang, Yu, Jia-ming
Format: pictorial research tables/charts Journal Article
Published: Wiley-Blackwell 10/8/2021
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=152922058&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 152922058
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 10/8/2021
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        152922058
        152922058
        152922058
        10.1155/2021/1752570
        152922058
      ppf: 1
      ppct: 12
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.
      aug:
        au:
          Liu, Yan-yun
          Yu, Li-hua
          Zhang, Juan
          Xie, Dao-jun
          Zhang, Xin-xiang
          Yu, Jia-ming
        affil: Graduate School, Anhui University of Traditional Chinese Medicine, Hefei, Anhui 230038, China
      sug:
        subj:
          Parkinson Disease Drug Therapy
          Sleep Disorders Drug Therapy
          Drugs, Chinese Herbal Analysis
          Drugs, Chinese Herbal Pharmacodynamics
          Pharmacy and Pharmacology Methods
          Molecular Docking Simulation
          Human
          Medicine, Chinese Traditional
          Phytochemicals Analysis
          Drug Synergism
          Drug Interactions
          Proteins Drug Effects
          Bioinformatics
          Genes Classification
          Signal Transduction
          Tumor Necrosis Factor
          Toll-Like Receptors
      ab: This study is aimed at exploring the possible mechanism of action of the Suanzaoren decoction (SZRD) in the treatment of Parkinson's disease with sleep disorder (PDSD) based on network pharmacology and molecular docking. Traditional Chinese Medicine Systems Pharmacology (TCMSP) was used to screen the bioactive components and targets of SZRD, and their targets were standardized using the UniProt platform. The disease targets of "Parkinson's disease (PD)" and "Sleep disorder (SD)" were collected by OMIM, GeneCards, and DisGeNET databases. Thereafter, the protein-protein interaction (PPI) network was constructed using the STRING platform and visualized by Cytoscape (3.7.2) software. Then, the DAVID platform was used to analyze the Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. Cytoscape (3.7.2) software was also used to construct the network of the "herb-component-target-pathway." The core active ingredients and core action targets of the drug were verified by molecular docking using AutoDock software. A total of 135 Chinese herbal components and 41 corresponding targets were predicted for the treatment of PDSD using SZRD. Fifteen important signaling pathways were screened, such as the cancer pathway, TNF signaling pathway, PI3K-AKT signaling pathway, HIF-1 signaling pathway, and Toll-like receptor signaling pathway. The results of molecular docking showed that the main active compounds could bind to the representative targets and exhibit good affinity. This study revealed that SZRD has the characteristics and advantages of "multicomponent, multitarget, and multipathway" in the treatment of PDSD; among these, the combination of the main active components of quercetin and kaempferol with the key targets of AKT1, IL6, MAPK1, TP53, and VEGFA may be one of the important mechanisms. This study provides a theoretical basis for further study of the material basis and molecular mechanism of SZRD in the treatment of PDSD.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N